![]()
30
| 4 | 2006
Klinisk Biokemi i Norden
Referanser
[
1
] M.Sogaard, S.K.Kjaer, S.Gayther. Ovarian can-
cer and genetic susceptibility in relation to the
BRCA1
and
BRCA2
genes. Occurrence, clini-
cal importance and intervention, Acta Obstet.
Gynecol.Scand., 85, (2006) 93-105.
[
2
] B.J.Lorenzo, K.Hemminki. Risk of cancer at sites
other than the breast in Swedish families eligible
for
BRCA1
or
BRCA2
mutation testing, Ann.
Oncol., 15, (2004) 1834-1841.
[
3
] Y.Miki, J.Swensen, D.Shattuck-Eidens,
P.A.Futreal, K.Harshman, S.Tavtigian, Q.Liu,
C.Cochran, L.M.Bennett, W.Ding, . A strong
candidate for the breast and ovarian cancer
susceptibility gene
BRCA1
, Science, 266, (1994)
66-71.
[
4
] R.Wooster, S.L.Neuhausen, J.Mangion, Y.Quirk,
D.Ford, N.Collins, K.Nguyen, S.Seal, T.Tran,
D.Averill, . Localization of a breast cancer
susceptibility gene,
BRCA2
, to chromosome
13q12-13, Science, 265, (1994) 2088-2090.
[
5
] D.Abeliovich, L.Kaduri, I.Lerer, N.Weinberg,
G.Amir, M.Sagi, J.Zlotogora, N.Heching, T.Peretz.
The founder mutations 185delAG and 5382insC
in
BRCA1
and 6174delT in
BRCA2
appear
in 60% of ovarian cancer and 30% of early-
onset breast cancer patients among Ashkenazi
women, Am.J.Hum.Genet., 60, (1997) 505-514.
[
6
] M.C.King, J.H.Marks, J.B.Mandell. Breast and
ovarian cancer risks due to inherited mutations
in
BRCA1
and
BRCA2
, Science, 302, (2003)
643-646.
[
7
] H.Jernstrom, N.Loman, O.T.Johannsson, A.Borg,
H.Olsson. Impact of teenage oral contraceptive
use in a population-based series of early-onset
breast cancer cases who have undergone BRCA
mutation testing, Eur.J.Cancer, 41, (2005) 2312-
2320.
[
8
] A.R.Venkitaraman. Cancer susceptibility and
the functions of
BRCA1
and
BRCA2
, Cell, 108,
(2002) 171-182.
[
9
] A.Tutt, A.Ashworth. The relationship between
the roles of BRCA genes in DNA repair and can-
cer predisposition, Trends Mol.Med., 8, (2002)
571-576.
[
10
] A.Antoniou, P.D.Pharoah, S.Narod, H.A.Risch,
J.E.Eyfjord, J.L.Hopper, N.Loman, H.Olsson,
O.Johannsson, A.Borg, B.Pasini, P.Radice,
S.Manoukian, D.M.Eccles, N.Tang, E.Olah,
H.Anton-Culver, E.Warner, J.Lubinski, J.Gronwald,
B.Gorski, H.Tulinius, S.Thorlacius, H.Eerola,
H.Nevanlinna, K.Syrjakoski, O.P.Kallioniemi,
D.Thompson, C.Evans, J.Peto, F.Lalloo, D.G.Evans,
D.F.Easton. Average risks of breast and ova-
rian cancer associated with
BRCA1
or
BRCA2
mutations detected in case Series unselected for
family history: a combined analysis of 22 studies,
Am.J.Hum.Genet., 72, (2003) 1117-1130.
[
11
] P.Moller, A.Borg, K.Heimdal, J.Apold, J.Vallon-
Christersson, E.Hovig, L.Maehle. The
BRCA1
syn-
drome and other inherited breast or breast-ova-
rian cancers in a Norwegian prospective series,
Eur.J.Cancer, 37, (2001) 1027-1032.
[
12
] G.
Johannesdottir,
J.Gudmundsson,
J.T.Bergthorsson, A.Arason, B.A.Agnarsson,
G.Eiriksdottir,
O.T.Johannsson,
A.Borg,
S.Ingvarsson,
D.F.Easton,
V.Egilsson,
R.B.Barkardottir. High prevalence of the 999del5
mutation in icelandic breast and ovarian cancer
patients, Cancer Res., 56, (1996) 3663-3665.
[
13
] A.Bergman, A.Flodin, Y.Engwall, E.L.Arkblad,
K.Berg, Z.Einbeigi, T.Martinsson, J.Wahlstrom,
P.Karlsson, M.Nordling. A high frequency of
germline
BRCA1
/2 mutations in western Sweden
detected with complementary screening techni-
ques, Fam.Cancer, 4, (2005) 89-96.
[
14
] L.Sarantaus, P.Vahteristo, E.Bloom, A.Tamminen,
L.Unkila-Kallio, R.Butzow, H.Nevanlinna.
BRCA1
and
BRCA2
mutations among 233 unselected
Finnish ovarian carcinoma patients, Eur.J.Hum.
Genet., 9, (2001) 424-430.
[
15
] J.T.Bergthorsson, B.Ejlertsen, J.H.Olsen, A.Borg,
K.V.Nielsen, R.B.Barkardottir, S.Klausen,
H.T.Mouridsen, K.Winther, K.Fenger, A.Niebuhr,
T.L.Harboe, E.Niebuhr.
BRCA1
and
BRCA2
muta-
tion status and cancer family history of Danish
women affected with multifocal or bilateral
breast cancer at a young age, J.Med.Genet., 38,
(2001) 361-368.
[
16
] P.Moller, K.Heimdal, J.Apold, A.Fredriksen,
A.Borg, E.Hovig, A.Hagen, B.Hagen, J.C.Pedersen,
L.Maehle. Genetic epidemiology of
BRCA1
muta-
tions in Norway, Eur.J.Cancer, 37, (2001) 2428-
2434.
(Fortsat fra side 29)
